Stock Options and Restricted Stock	6 Months Ended
Jun. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Options and Restricted Stock	Note 2. Stock Options and Restricted Stock As of June 30, 2020, the Company has two equity incentive plans: the AMERISAFE Non-Employee Director Restricted Stock Plan (the “Restricted Stock Plan”) and the AMERISAFE 2012 Equity and Incentive Compensation Plan (the “2012 Incentive Plan”). In connection with the approval of the 2012 Incentive Plan by the Company’s shareholders, no further grants were made under the AMERISAFE 2005 Incentive Plan. There are no outstanding options or restricted stock awards under the 2005 Incentive Plan. See Note 12 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019 for additional information regarding the Company’s incentive plans. During the six months ended June 30, 2020, the Company issued 23,207 shares of common stock pursuant to vested performance awards and 5,269 shares of restricted common stock to non-employee directors. The market value of these shares totaled $1.8 million. During the six months ended June 30, 2019, the Company issued 9,391 shares of common stock pursuant to vested performance awards and 9,000 shares of restricted common stock to executive officers. During the six months ended June 30, 2019, the Company issued 4,890 shares of restricted common stock to non-employee directors. The market value of these shares totaled $1.4 million. During the six months ended June 30, 2020, there were no exercises of options to purchase common stock. During the six months ended June 30, 2019, options to purchase 5,000 shares of common stock were exercised. In connection with these exercises, the Company received $20 thousand of stock option proceeds. The Company had no stock options outstanding as of June 30, 2020. The Company recognized share-based compensation expense of $1.0 million in the quarter ended June 30, 2020 and a negative share-based compensation expense of $0.1 million for the same period in 2019. The Company recognized share-based compensation expense of $1.8 million in the six months ended June 30, 2020 and $0.5 million for the same period in 2019.

Stock Options and Restricted Stock

6 Months Ended

Jun. 30, 2020

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Note 2. Stock Options and Restricted Stock

As of June 30, 2020, the Company has two equity incentive plans: the AMERISAFE Non-Employee Director Restricted Stock Plan (the “Restricted Stock Plan”) and the AMERISAFE 2012 Equity and Incentive Compensation Plan (the “2012 Incentive Plan”). In connection with the approval of the 2012 Incentive Plan by the Company’s shareholders, no further grants were made under the AMERISAFE 2005 Incentive Plan. There are no outstanding options or restricted stock awards under the 2005 Incentive Plan. See Note 12 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019 for additional information regarding the Company’s incentive plans.

During the six months ended June 30, 2020, the Company issued 23,207 shares of common stock pursuant to vested performance awards and 5,269 shares of restricted common stock to non-employee directors. The market value of these shares totaled $1.8 million. During the six months ended June 30, 2019, the Company issued 9,391 shares of common stock pursuant to vested performance awards and 9,000 shares of restricted common stock to executive officers. During the six months ended June 30, 2019, the Company issued 4,890 shares of restricted common stock to non-employee directors. The market value of these shares totaled $1.4 million.

During the six months ended June 30, 2020, there were no exercises of options to purchase common stock. During the six months ended June 30, 2019, options to purchase 5,000 shares of common stock were exercised. In connection with these exercises, the Company received $20 thousand of stock option proceeds. The Company had no stock options outstanding as of June 30, 2020.

The Company recognized share-based compensation expense of $1.0 million in the quarter ended June 30, 2020 and a negative share-based compensation expense of $0.1 million for the same period in 2019. The Company recognized share-based compensation expense of $1.8 million in the six months ended June 30, 2020 and $0.5 million for the same period in 2019.